KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Chemed's Liabilities and Shareholders Equity fell 824.08% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year decrease of 237.08%. This contributed to the annual value of $1.7 billion for FY2024, which is 2.88% up from last year.
  • Per Chemed's latest filing, its Liabilities and Shareholders Equity stood at $1.6 billion for Q3 2025, which was down 824.08% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Chemed's Liabilities and Shareholders Equity registered a high of $1.8 billion during Q3 2024, and its lowest value of $1.3 billion during Q1 2022.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $1.5 billion (2023), whereas its average is $1.5 billion.
  • As far as peak fluctuations go, Chemed's Liabilities and Shareholders Equity tumbled by 1045.01% in 2022, and later surged by 2071.35% in 2024.
  • Quarter analysis of 5 years shows Chemed's Liabilities and Shareholders Equity stood at $1.3 billion in 2021, then increased by 7.39% to $1.4 billion in 2022, then increased by 15.68% to $1.7 billion in 2023, then rose by 0.03% to $1.7 billion in 2024, then dropped by 2.69% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.7 billion for Q2 2025, and $1.7 billion during Q1 2025.